Comparative analysis of European bat lyssavirus 1 pathogenicity in the mouse model

PLoS Neglected Tropical Diseases

Volumn 11, Issue 6, 2017, Pages

  Eggerbauer, Elisa ^a   Pfaff, Florian ^a   Finke, Stefan ^a   Höper, Dirk ^a   Beer, Martin ^a   Mettenleiter, Thomas C ^a   Nolden, Tobias ^a,b   Teifke, Jens Peter ^a   Müller, Thomas ^a   Freuling, Conrad M ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b ViraTherapeutics GmbH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EUROPEAN BAT LYSSAVIRUS 1; FEMALE; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; GENE SEQUENCE; IMMUNOHISTOCHEMISTRY; LYSSAVIRUS; MOUSE; NEUROBLASTOMA CELL LINE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; RNA EXTRACTION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS REPLICATION; VIRUS TITRATION; VIRUS VIRULENCE; ANIMAL; BAT; BRAIN; DISEASE MODEL; DRUG ADMINISTRATION ROUTE; ISOLATION AND PURIFICATION; PATHOGENICITY; PATHOLOGY; RABIES; SURVIVAL ANALYSIS; VIROLOGY;

ANIMALS; BRAIN; CHIROPTERA; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; IMMUNOHISTOCHEMISTRY; LYSSAVIRUS; MICE; RABIES; SURVIVAL ANALYSIS;

EID: 85021627488     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0005668     Document Type: Article

References (68)

1. Gunawardena PS, Marston DA, Ellis RJ, Wise EL, Karawita AC, Breed AC, et al. Lyssavirus in Indian Flying Foxes, Sri Lanka. Emerg Infect Dis. 2016;22(8):1456–9. Epub 2016/07/21. doi: 10.3201/eid2208.151986 27434858.
2. ICTV. Virus Taxonomy: 2015 Release https://talk.ictvonline.org/taxonomy/: International Committee on Taxonomy of Viruses (ICTV); 2015.
3. Arechiga Ceballos N, Moron SV, Berciano JM, Nicolas O, Lopez CA, Juste J, et al. Novel lyssavirus in bat, Spain. Emerg Infect Dis. 2013;19(5):793–5. Epub 2013/05/08. doi: 10.3201/eid1905.121071 23648051.
4. Badrane H, Tordo N, Host Switching in Lyssavirus History from the Chiroptera to the Carnivora Orders. J Virol. 2001;75(17):104–8096. doi: 10.1128/JVI.75.17.8096-8104.2001 11483755
5. Messenger SL, Smith JS, Rupprecht CE, Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin Infect Dis. 2002;35(6):47–738. doi: 10.1086/342387 12203172
6. Van Thiel PP, van den Hoek JA, Eftiov F, Tepaske R, Zaarijer HJ, Spanjaard L, et al. Fatal case of human rabies (Duvenhage virus) from a bat in Kenya: The Netherlands, December 2007. Euro Surveill. 2008;132.
7. Johnson N, Vos A, Freuling C, Tordo N, Fooks AR, Müller T, Human rabies due to lyssavirus infection of bat origin. Vet Microbiol. 2010;142(3–4):151–9. doi: 10.1016/j.vetmic.2010.02.001. 20188498
8. Mohr W, Die Tollwut. Med Klin. 1957;52(24):1057–60.
9. Bourhy H, Kissi B, Lafon M, Sacramento D, Tordo N, Antigenic and Molecular Characterization of Bat Rabies Virus in Europe. J Clin Microbiol. 1992;30(9):2419–26. 1401009
10. Banyard AC, Hayman D, Freuling CM, Müller T, Fooks AR, Johnson N, Jackson AC, Bat rabies. In: Rabies: Scientific Basis of the Disease and Its Management. 3. 3rd ed. New York: Academic Press; 2013. p. 215–67.
11. Kuzmin IV, Hughes GJ, Botvinkin AD, Orciari LA, Rupprecht CE, Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res. 2005;111(1):28–43. doi: 10.1016/j.virusres.2005.03.008 15896400
12. Freuling CM, Beer M, Conraths FJ, Finke S, Hoffmann B, Keller B, et al. Novel Lyssavirus in Natterer's Bat, Germany. Emerg Infect Dis. 2011;17(8):1519–22. doi: 10.3201/eid1708.110201 21801640.
13. Schatz J, Fooks AR, McElhinney L, Horton D, Echevarria J, Vazquez-Moron S, et al. Bat Rabies Surveillance in Europe. Zoonoses Public Health. 2013;60(1):22–34. Epub 2012/09/12. doi: 10.1111/zph.12002 22963584.
14. Vazquez-Moron S, Juste J, Ibanez C, Berciano JM, Echevarria JE, Phylogeny of European bat Lyssavirus 1 in Eptesicus isabellinus bats, Spain. Emerg Infect Dis. 2011;17(3):520–3. Epub 2011/03/12. doi: 10.3201/eid1703.100894 21392449.
15. Schatz J, Freuling CM, Auer E, Goharriz H, Harbusch C, Johnson N, et al. Enhanced Passive Bat Rabies Surveillance in Indigenous Bat Species from Germany—A Retrospective Study. PLOS Negl Trop Dis. 2014;8(5):e2835. doi: 10.1371/journal.pntd.0002835 24784117
16. Tjornehoj K, Fooks AR, Agerholm JS, Ronsholt L, Natural and Experimental Infection of Sheep with European Bat Lyssavirus Type-1 of Danish Bat Origin. J Comp Pathol. 2006;134(2–3):190–201. doi: 10.1016/j.jcpa.2005.10.005 16545840
17. Dacheux L, Larrous F, Mailles A, Boisseleau D, Delmas O, Biron C, et al. European bat lyssavirus transmission among cats, Europe. Emerg Infect Dis. 2009;15(2):280–4. doi: 10.3201/eid1502.080637 19193273
18. Müller T, Cox J, Peter W, Schäfer R, Johnson N, McElhinney LM, et al. Spill-over of European bat lyssavirus type 1 into a stone marten (Martes foina) in Germany. J Vet Med Ser B. 2004;51(2):49–54.
19. Selimov MA, Tatarov AG, Botvinkin AD, Klueva EV, Kulikova LG, Khismatullina NA, Rabies-related Yuli virus; identification with a panel of monoclonal antibodies. Acta Virol. 1989;33(6):542–6. 2576595
20. Kuzmin IV, Botvinkin AD, Poleschuk EM, Orciari LA, Rupprecht CE, Bat rabies surveillance in the former Soviet Union. Dev Biol (Basel). 2006;125:273–82.
21. Marston DA, McElhinney LM, Johnson N, Müller T, Conzelmann KK, Tordo N, et al. Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region. J Gen Virol. 2007;88(4):1302–14.
22. Wunner Conzelmann, Jackson AC, Viral Proteins. In: Rabies: Scientific basis of the disease and its management. 3 ed. San DiegoAcademic Press; 2013. p. 21–32.
23. Amengual B, Whitby JE, King A, Cobo JS, Bourhy H, Evolution of European bat lyssaviruses. J Gen Virol. 1997;78(9):2319–28.
24. Davis PL, Holmes EC, Larrous F, van der Poel WH, Tjornehoj K, Alonso W, et al. Phylogeography, population dynamics, and molecular evoluation of European Bat Lyssaviruses. J Virol. 2005;79(16):10487–97. doi: 10.1128/JVI.79.16.10487-10497.2005 16051841
25. Johnson N, Freuling CM, Marston DA, Tordo N, Fooks AR, Müller T, Identification of European bat lyssavirus isolates with short genomic insertions. Virus Res. 2007;128(1–2):140–3. doi: 10.1016/j.virusres.2007.04.012 17521764
26. Freuling C, Hoffmann B, Selhorst T, Conraths FJ, Kliemt A, Schatz J, et al. New insights into the genetics of EBLV-1 from Germany. Berl Munch Tierarztl Wochenschr. 2012;125(5–6):259–63. 22712425
27. Vos A, Müller T, Cox J, Neubert L, Fooks AR, Susceptibility of ferrets (Mustela putorius furo) to experimentally induced rabies with European Bat Lyssaviruses (EBLV). J Vet Med Ser B. 2004;51(2):55–60.
28. Healy DM, Brookes SM, Banyard AC, Núñez A, Cosby SL, Fooks AR, Pathobiology of rabies virus and the European bat lyssaviruses in experimentally infected mice. Virus Res. 2013;172(1–2):46–53. http://dx.doi.org/10.1016/j.virusres.2012.12.011. 23274107
29. Hicks DJ, Nunez A, Healy DM, Brookes SM, Johnson N, Fooks AR, Comparative Pathological Study of the Murine Brain after Experimental Infection with Classical Rabies Virus and European Bat Lyssaviruses. J Comp Pathol. 2008.
30. Badrane H, Bahloul C, Perrin P, Tordo N, Evidence of Two Lyssavirus Phylogroups with Distinct Pathogenicity and Immunogenicity. J Virol. 2001;75(7):3268–76. doi: 10.1128/JVI.75.7.3268-3276.2001 11238853
31. Montano-Hirose JA, Lafage M, Weber P, Badrane H, Tordo N, Lafon M, Protective Activity of A Murine Monoclonal-Antibody Against European Bat Lyssavirus-1 (Ebl1) Infection in Mice. Vaccine. 1993;11(12):1259–66. 8256507
32. Brookes SM, Parsons G, Johnson N, McElhinney LM, Fooks AR, Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine. 2005;23(32):4101–9. doi: 10.1016/j.vaccine.2005.03.037 15964478
33. Vos A, Müller T, Neubert L, Zurbriggen A, Botteron C, Pöhle D, et al. Rabies in Red Foxes (Vulpes vulpes) Experimentally Infected with European Bat Lyssavirus Type 1. J Vet Med Ser B. 2004;51(7):327–32.
34. Markotter W, Kuzmin IV, Rupprecht CE, Nel LH, Lagos bat virus virulence in mice inoculated by the peripheral route. Epidemiol Infect. 2009;137(8):1155–62. doi: 10.1017/S0950268808001945 19144249.
35. Kgaladi J, Nel LH, Markotter W, Comparison of pathogenic domains of rabies and African rabies-related lyssaviruses and pathogenicity observed in mice. Onderstepoort J Veterinary Research2013;Mar8;80(1):E1–E13. doi: 10.4102/ojvr.v80i1.511 23718883
36. Cunha EM, Nassar AF, Lara Mdo C, Villalobos EC, Sato G, Kobayashi Y, et al. Pathogenicity of different rabies virus isolates and protection test in vaccinated mice. Rev Inst Med Trop Sao Paulo. 2010;52(5):231–6. 21049225.
37. Orbanz J, Finke S, Generation of recombinant European bat lyssavirus type 1 and inter-genotypic compatibility of lyssavirus genotype 1 and 5 antigenome promoters. Arch Virol. 2010;155(10):1631–41. doi: 10.1007/s00705-010-0743-8 20614145
38. Nolden T, Pfaff F, Nemitz S, Freuling CM, Hoper D, Muller T, et al. Reverse genetics in high throughput: rapid generation of complete negative strand RNA virus cDNA clones and recombinant viruses thereof. Sci Rep. 2016;6:23887. Epub 2016/04/06. doi: 10.1038/srep23887 27046474.
39. Vos A, Nolden T, Habla C, Finke S, Freuling CM, Teifke JP, et al. Raccoons (Procyon lotor) in Germany as potential reservoir species for Lyssaviruses. Eur J Wildl Res. 2013;59:637–43. doi: 10.1007/s10344-013-0714-y
40. Kärber G, Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Path Pharmakol. 1931;162:480–3.
41. Dean DJ, Abelseth MK, Athanasiu P, Meslin FX, Kaplan MM, Koprowski H, The fluorescence antibody test In: Laboratory techniques in rabies. 4th ed. Geneva: World Health Organization; 1996. p. 88–93.
42. Brookes SM, Klopfleisch R, Müller T, Healy DM, Teifke JP, Lange E, et al. Susceptibility of sheep to European bat lyssavirus type-1 and -2 infection: A clinical pathogenesis study. Vet Microbiol. 2007;125(3–4):210–23. doi: 10.1016/j.vetmic.2007.05.031 17706900
43. Schatz J, Teifke JP, Mettenleiter TC, Aue D, Stiefel D, Müller T, et al. Lyssavirus distribution in naturally infected bats from Germany. Vet Microbiol. 2014;169(1–2):33–41. doi: 10.1016/j.vetmic.2013.12.004 24440375
44. Cox JH, Schneider LG, Prophylactic Immunization of Humans Against Rabies by Intradermal Inoculation of Human Diploid Cell Culture Vaccine. J Clin Microbiol. 1976;3(2):96–101. 1254722
45. Malerczyk C, Freuling C, Gniel D, Giesen A, Selhorst T, Müller T, Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species. Hum Vaccin Immunother. 2014;10(10):2799–804. doi: 10.4161/21645515.2014.972741 25483634.
46. Juozapaitis M, Aguiar Moreira E, Mena I, Giese S, Riegger D, Pohlmann A, et al. An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus. Nat Commun. 2014;5:4448. doi: 10.1038/ncomms5448 25055345.
47. Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, et al. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics. 2012;28(12):1647–9. doi: 10.1093/bioinformatics/bts199 22543367.
48. Kumar S, Stecher G, Tamura K, MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol. 2016;33(7):1870–4. doi: 10.1093/molbev/msw054 27004904.
49. Johnson N, Vos A, Neubert L, Freuling C, Mansfield K, Kaipf I, et al. Experimental study of European bat lyssavirus type-2 infection in Daubenton's bats (Myotis daubentonii). J Gen Virol. 2008;89(11):2662–72.
50. Freuling C, Vos A, Johnson N, Kaipf I, Denzinger A, Neubert L, et al. Experimental infection of serotine bats (Eptesicus serotinus) with European bat lyssavirus type 1a. J Gen Virol. 2009;90(10):2493–502.
51. Jackson AC, Fu ZF, Jackson AC, Pathogenesis. In: Rabies: Scientific basis of the disease and its management. 3 ed. San Diego: Academic Press; 2013. p. 299–350.
52. Ceccaldi PE, Fayet J, Conzelmann KK, Tsiang H, Infection characteristics of rabies virus variants with deletion or insertion in the pseudogene sequence. J Neurovirol. 1998;4(1):115–9. 9531019
53. Etessami R, Conzelmann KK, Marion R, Tsiang H, Ceccaldi PE, Neuronal expression of foreign genes with recombinant rabies virus variants. Rev Neurol (Paris). 2000;156(3):236–41.
54. Faber M, Pulmanausahakul R, Nagao K, Prosniak M, Rice AB, Koprowski H, et al. Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc Natl Acad Sci U S A Biol Sci. 2004;101(46):16328–32.
55. Johnson N, Phillpotts R, Fooks AR, Airborne transmission of lyssaviruses. J Med Microbiol. 2006;55(Pt 6):785–90. doi: 10.1099/jmm.0.46370-0 16687600
56. Sinchaisri TA, Nagata T, Yoshikawa Y, Kai C, Yamanouchi K, Immunohistochemical and histopathological study of experimental rabies infection in mice. J Vet Med Sci. 1992;54(3):409–16. 1643165.
57. Hronovsk V, Benda R, Experimental Inhalation Infection of Laboratory Rodents with Rabies Virus. Acta Virol. 1969;13(3):193–7. 4389107
58. Hronovsky V, Benda R, Development of Inhalation Rabies Infection in Suckling Guinea Pigs. Acta Virol. 1969;13(3):198. 4389108
59. Rosseels V, Naze F, De Craeye S, Francart A, Kalai M, Van Gucht S, A non-invasive intranasal inoculation technique using isoflurane anesthesia to infect the brain of mice with rabies virus. J Virol Methods. 2011;173(1):127–36. doi: 10.1016/j.jviromet.2011.01.019 21295615.
60. Constantine DG, Rabies Transmission by Nonbite Route. Public Health Rep. 1962;77(4):287–9.
61. Gibbons RV, Cryptogenic rabies, bats, and the question of aerosol transmission. Ann Emerg Med. 2002;39(5):528–36. 11973559
62. Rieder M, Brzozka K, Pfaller CK, Cox JH, Stitz L, Conzelmann KK, Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity. J Virol. 2011;85(2):842–52. Epub 2010/11/19. doi: 10.1128/JVI.01427-10 21084487.
63. Conzelmann KK, Cox JH, Schneider LG, Thiel HJ, Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. Virology. 1990;175(2):485–99. 2139267.
64. Lafay F, Coulon P, Astic L, Saucier D, Riche D, Holley A, et al. Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation. Virology. 1991;183(1):320–30. 2053286
65. Yamada K, Park CH, Noguchi K, Kojima D, Kubo T, Komiya N, et al. Serial passage of a street rabies virus in mouse neuroblastoma cells resulted in attenuation: Potential role of the additional N-glycosylation of a viral glycoprotein in the reduced pathogenicity of street rabies virus. Virus Res. 2012;165(1):34–45. doi: 10.1016/j.virusres.2012.01.002 22248643
66. Lepine P, On the evolution of fixed strains of rabies virus. J Hyg (Lond). 1938;38(2):180–4. 20475418.
67. Suzor R. M., Pasteur’s communications on hydrophobia. Hydrophobia—an account of M Pasteur′s system: Royal College of Physicians of London; 1887. p. 31–159.
68. Yamada K, Noguchi K, Nishizono A, Characterization of street rabies virus variants with an additional N-glycan at position 247 in the glycoprotein. Arch Virol. 2014;159(2):207–16. Epub 2013/08/08. doi: 10.1007/s00705-013-1805-5 23921623.